The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Recruiting	Phase 1 / Phase 2	2026-03-27		NCT05756322

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Lin BioScience Pty Ltd	1
Lin BioScience, Inc	1

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
China Medical University Hospital	Taichung	Taiwan	54
Hollywood Private Hospital	Nedlands	Australia	1
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences	Tianjin	China	1
Jining No.1 People'S Hospital	Jining	China	5
Moffitt Cancer Center	Tampa	United States	523
National Cheng Kung University Hospital	Tainan	Taiwan	53
National Taiwan University Hospital	Taipei	Taiwan	203
Pindara Private Hospital	Benowa	Australia	2
Q Medical Conselling	Perth	Australia	1
Robert H. Lurie Comprehensive Cancer Center of Northwestern University	Chicago	United States	16
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Baltimore	United States	24
The Alfred Hospital	Melbourne	Australia	7
The First Affiliated Hospital of Xinxiang Medical University	Xinxiang	China	16
The Royal Adelaide Hospital	Adelaide	Australia	1
The University of Kansas Hospital	Fairway	United States	1
UNC Hospitals, The University of North Carolina at Chapel Hill	Chapel Hill	United States	3
Wollongong Private Hospital	Wollongong	Australia	1